Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | HBB | P68871 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12208028 | 0.90 | MAPT (0.43) | MAPTLMNATP53TSHRHTT | |
| SCHEMBL9346534 | 0.79 | — | — | |
| SCHEMBL696455 | 0.71 | — | — | |
| SCHEMBL17635564 | 0.69 | — | — | |
| SCHEMBL28319122 | 0.68 | — | — | |
| SCHEMBL314234 | 0.67 | ALDH1A1 (0.38) | MAPTLMNATP53TSHRHTT | |
| SCHEMBL17634994 | 0.65 | MAPT (0.35) | MAPTLMNATP53TSHRHTT | |
| SCHEMBL15493984 | 0.64 | MAPT (0.33) | MAPTLMNATP53TSHRHTT | |
| SCHEMBL15494273 | 0.63 | MAPT (0.38) | MAPTLMNATP53TSHRHTT | |
| SCHEMBL5494441 | 0.63 | MAPT (0.32) | MAPTLMNATP53TSHRHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230173079-A1 | Conjugate Molecules | DIVERSE BIOTECH, INC. (US) | 2023-06-08 | — | — | US | disclosed |
| US-20230173079-A1 | Conjugate Molecules | DIVERSE BIOTECH, INC. (US) | 2023-06-08 | — | — | US | disclosed |
| WO-2021076197-A1 | CONJUGATE MOLECULES | DIVERSE BIOTECH, INC. (US) | 2021-04-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230173079-A1 | Conjugate Molecules | CNR2, CNR1, MAG | MAPT 1825/4885LMNA 3795/4885TP53 2077/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.